A single-tube multiparameter seven-colour flow cytometry strategy for the detection of malignant plasma cells in multiple myeloma

by Robillard, N, Béné, M C, Moreau, P, Wuillème, S
Published 2013

Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma

by Maïga, S, Gomez-Bougie, P, Bonnaud, S, Gratas, C, Moreau, P, Le Gouill, S, Pellat-Deceunynck, C, Amiot, M
Published 2013

Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK

by Brosseau, C, Dousset, C, Touzeau, C, Maïga, S, Moreau, P, Amiot, M, Le Gouill, S, Pellat-Deceunynck, C
Published 2014

Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients

by Bradwell, A, Harding, S, Fourrier, N, Mathiot, C, Attal, M, Moreau, P, Harousseau, J-L, Avet-Loiseau, H
Published 2013

Lack of BRAF V600E mutation in human myeloma cell lines established from myeloma patients with extramedullary disease

by Lodé, L, Moreau, P, Ménard, A, Godon, C, Touzeau, C, Amiot, M, Le Gouill, S, Béné, M C, Pellat-Deceunynck, C
Published 2013

Difficulties in immunofixation analysis: a concordance study on the IFM 2007-02 trial

by Caillon, H, Dejoie, T, Le Loupp, A-G, Azoulay-Fauconnier, C, Masson, D, Moreau, P, Denis, M, Avet-Loiseau, H
Published 2013

Multiprobe Study of the Solid Electrolyte Interphase on Silicon-Based Electrodes in Full-Cell Configuration

by Dupré, N., Moreau, P., De Vito, E., Quazuguel, L., Boniface, M., Bordes, A., Rudisch, C., Bayle-Guillemaud, P., Guyomard, D.
Published 2016

The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction

by Descamps, G, Gomez-Bougie, P, Tamburini, J, Green, A, Bouscary, D, Maïga, S, Moreau, P, Le Gouill, S, Pellat-Deceunynck, C, Amiot, M
Published 2012

Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma

by Siegel, D S, Richardson, P, Dimopoulos, M, Moreau, P, Mitsiades, C, Weber, D, Houp, J, Gause, C, Vuocolo, S, Eid, J, Graef, T, Anderson, K C
Published 2014

The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma

by Touzeau, C, Dousset, C, Le Gouill, S, Sampath, D, Leverson, J D, Souers, A J, Maïga, S, Béné, M C, Moreau, P, Pellat-Deceunynck, C, Amiot, M
Published 2014

Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma

by Siegel, D S, Richardson, P, Dimopoulos, M, Moreau, P, Mitsiades, C, Weber, D, Houp, J, Gause, C, Vuocolo, S, Eid, J, Graef, T, Anderson, K C
Published 2014

Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells

by Chiron, D, Maïga, S, Surget, S, Descamps, G, Gomez-Bougie, P, Traore, S, Robillard, N, Moreau, P, Le Gouill, S, Bataille, R, Amiot, M, Pellat-Deceunynck, C
Published 2013

Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

by Dimopoulos, M A, Leleu, X, Palumbo, A, Moreau, P, Delforge, M, Cavo, M, Ludwig, H, Morgan, G J, Davies, F E, Sonneveld, P, Schey, S A, Zweegman, S, Hansson, M, Weisel, K, Mateos, M V, Facon, T, Miguel, J F S
Published 2014

Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer’s disease and frontotemporal lobar degeneration...

by Melis, V., Zabke, C., Stamer, K., Magbagbeolu, M., Schwab, K., Marschall, P., Veh, R. W., Bachmann, S., Deiana, S., Moreau, P.-H., Davidson, K., Harrington, K. A., Rickard, J. E., Horsley, D., Garman, R., Mazurkiewicz, M., Niewiadomska, G., Wischik, C. M., Harrington, C. R., Riedel, G., Theuring, F.
Published 2014